Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Sheppard

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 2, 2023
Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKIConstantinos Koshiaris, Lucinda Archer, Sarah Lay-Flurrie, et al.
Plos Medicine|September 17, 2025
Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort studyTakeshi Fujiwara, Constantinos Koshiaris, Ting Cai, et al.
Nature Communications|October 23, 2025
Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY modelsConstantinos Koshiaris, Ariel Wang, Lucinda Archer, et al.
The Journal of Infection|May 18, 2021
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort studyAzmaeen Zarif, Mark Joy, Julian Sherlock, et al.
Trials|February 14, 2026
Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trialMelanie Carr, Nicola Kenealy, Ly-Mee Yu, et al.
Journal of Hypertension|May 16, 2025
Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendationsAriel Wang, Constantinos Koshiaris, Lucinda Archer, et al.
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
American Journal of Hypertension|January 18, 2022
Predicting Out-of-Office Blood Pressure in a Diverse US PopulationBrandon K Bellows, Jingyu Xu, James P Sheppard, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 2, 2023
Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKIConstantinos Koshiaris, Lucinda Archer, Sarah Lay-Flurrie, et al.
Plos Medicine|September 17, 2025
Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort studyTakeshi Fujiwara, Constantinos Koshiaris, Ting Cai, et al.
Nature Communications|October 23, 2025
Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY modelsConstantinos Koshiaris, Ariel Wang, Lucinda Archer, et al.
The Journal of Infection|May 18, 2021
The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort studyAzmaeen Zarif, Mark Joy, Julian Sherlock, et al.
Trials|February 14, 2026
Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trialMelanie Carr, Nicola Kenealy, Ly-Mee Yu, et al.
Journal of Hypertension|May 16, 2025
Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendationsAriel Wang, Constantinos Koshiaris, Lucinda Archer, et al.
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
American Journal of Hypertension|January 18, 2022
Predicting Out-of-Office Blood Pressure in a Diverse US PopulationBrandon K Bellows, Jingyu Xu, James P Sheppard, et al.
Pageof 11